271 related articles for article (PubMed ID: 27164915)
1. MRI in multiple myeloma: a pictorial review of diagnostic and post-treatment findings.
Dutoit JC; Verstraete KL
Insights Imaging; 2016 Aug; 7(4):553-69. PubMed ID: 27164915
[TBL] [Abstract][Full Text] [Related]
2. Review of diffusion-weighted imaging and dynamic contrast-enhanced MRI for multiple myeloma and its precursors (monoclonal gammopathy of undetermined significance and smouldering myeloma).
Van Den Berghe T; Verstraete KL; Lecouvet FE; Lejoly M; Dutoit J
Skeletal Radiol; 2022 Jan; 51(1):101-122. PubMed ID: 34523007
[TBL] [Abstract][Full Text] [Related]
3. Whole-body MRI, dynamic contrast-enhanced MRI, and diffusion-weighted imaging for the staging of multiple myeloma.
Dutoit JC; Verstraete KL
Skeletal Radiol; 2017 Jun; 46(6):733-750. PubMed ID: 28289855
[TBL] [Abstract][Full Text] [Related]
4. Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma.
Dutoit JC; Vanderkerken MA; Verstraete KL
Eur J Radiol; 2013 Sep; 82(9):1444-52. PubMed ID: 23726124
[TBL] [Abstract][Full Text] [Related]
5. Whole-Body Functional MRI and PET/MRI in Multiple Myeloma.
Mulé S; Reizine E; Blanc-Durand P; Baranes L; Zerbib P; Burns R; Nouri R; Itti E; Luciani A
Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33121132
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.
Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS
Acta Radiol; 2008 May; 49(4):427-35. PubMed ID: 18415787
[TBL] [Abstract][Full Text] [Related]
7. [Use of whole-body diffusion-weighted magnetic resonance imaging for the diagnosis of and therapeutic response in multiple myeloma].
Puskás T; Henits I
Orv Hetil; 2014 Aug; 155(31):1241-5. PubMed ID: 25095285
[TBL] [Abstract][Full Text] [Related]
8. Pictorial review of whole body MRI in myeloma: emphasis on diffusion-weighted imaging.
Hameed M; Sandhu A; Soneji N; Amiras D; Rockall A; Messiou C; Wallitt K; Barwick TD
Br J Radiol; 2020 Nov; 93(1115):20200312. PubMed ID: 32667830
[TBL] [Abstract][Full Text] [Related]
9. Functional and molecular MRI of the bone marrow in multiple myeloma.
Koutoulidis V; Papanikolaou N; Moulopoulos LA
Br J Radiol; 2018 Jul; 91(1088):20170389. PubMed ID: 29393672
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow abnormalities and early bone lesions in multiple myeloma and its precursor disease: a prospective study using functional and morphologic imaging.
Bhutani M; Turkbey B; Tan E; Korde N; Kwok M; Manasanch EE; Tageja N; Mailankody S; Roschewski M; Mulquin M; Carpenter A; Lamping E; Minter AR; Weiss BM; Mena E; Lindenberg L; Calvo KR; Maric I; Usmani SZ; Choyke PL; Kurdziel K; Landgren O
Leuk Lymphoma; 2016 May; 57(5):1114-21. PubMed ID: 26690712
[TBL] [Abstract][Full Text] [Related]
11. Combined evaluation of conventional MRI, dynamic contrast-enhanced MRI and diffusion weighted imaging for response evaluation of patients with multiple myeloma.
Dutoit JC; Claus E; Offner F; Noens L; Delanghe J; Verstraete KL
Eur J Radiol; 2016 Feb; 85(2):373-82. PubMed ID: 26781143
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of whole-body MRI in patients with monoclonal gammopathy of undetermined significance.
Hillengass J; Weber MA; Kilk K; Listl K; Wagner-Gund B; Hillengass M; Hielscher T; Farid A; Neben K; Delorme S; Landgren O; Goldschmidt H
Leukemia; 2014 Jan; 28(1):174-8. PubMed ID: 23958921
[TBL] [Abstract][Full Text] [Related]
13. Role of MRI for the diagnosis and prognosis of multiple myeloma.
Baur-Melnyk A; Buhmann S; Dürr HR; Reiser M
Eur J Radiol; 2005 Jul; 55(1):56-63. PubMed ID: 15950101
[TBL] [Abstract][Full Text] [Related]
14. Increased microcirculation detected by dynamic contrast-enhanced magnetic resonance imaging is of prognostic significance in asymptomatic myeloma.
Hillengass J; Ritsch J; Merz M; Wagner B; Kunz C; Hielscher T; Laue H; Bäuerle T; Zechmann CM; Ho AD; Schlemmer HP; Goldschmidt H; Moehler TM; Delorme S
Br J Haematol; 2016 Jul; 174(1):127-35. PubMed ID: 26991959
[TBL] [Abstract][Full Text] [Related]
15. Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity.
Kloth JK; Hillengass J; Listl K; Kilk K; Hielscher T; Landgren O; Delorme S; Goldschmidt H; Kauczor HU; Weber MA
Int J Cancer; 2014 Nov; 135(10):2380-6. PubMed ID: 24706394
[TBL] [Abstract][Full Text] [Related]
16. Improved contrast for myeloma focal lesions with T2-weighted Dixon images compared to T1-weighted images.
Danner A; Brumpt E; Alilet M; Tio G; Omoumi P; Aubry S
Diagn Interv Imaging; 2019 Sep; 100(9):513-519. PubMed ID: 31130374
[TBL] [Abstract][Full Text] [Related]
17. Intravoxel Incoherent Motion Diffusion-weighted Imaging of Multiple Myeloma Lesions: Correlation with Whole-Body Dynamic Contrast Agent-enhanced MR Imaging.
Bourillon C; Rahmouni A; Lin C; Belhadj K; Beaussart P; Vignaud A; Zerbib P; Pigneur F; Cuenod CA; Bessalem H; Cavet M; Boutekadjirt A; Haioun C; Luciani A
Radiology; 2015 Dec; 277(3):773-83. PubMed ID: 26131910
[TBL] [Abstract][Full Text] [Related]
18. Comparison of whole-body diffusion MRI and conventional radiological assessment in the staging of myeloma.
Narquin S; Ingrand P; Azais I; Delwail V; Vialle R; Boucebci S; Tasu JP
Diagn Interv Imaging; 2013 Jun; 94(6):629-36. PubMed ID: 23683788
[TBL] [Abstract][Full Text] [Related]
19. [Staging of multiple myeloma with MRI: comparison to MSCT and conventional radiography].
Baur-Melnyk A; Reiser M
Radiologe; 2004 Sep; 44(9):874-81. PubMed ID: 15365631
[TBL] [Abstract][Full Text] [Related]
20. The Role of Imaging in the Treatment of Patients With Multiple Myeloma in 2016.
Terpos E; Dimopoulos MA; Moulopoulos LA
Am Soc Clin Oncol Educ Book; 2016; 35():e407-17. PubMed ID: 27249748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
